Marjo Karjalainen

Person

Latest publications

  1. Celecoxib is a CYP1A2 inhibitor in vitro but not in vivo

    Karjalainen, M. J., Neuvonen, P. J. & Backman, J. T., 2008, In : European Journal of Clinical Pharmacology. 64, 5, p. 511-519 9 p.

    Research output: Contribution to journalArticleScientificpeer-review

  2. In vitro inhibition of CYP1A2 by model inhibitors, anti-inflammatory analgesics and female sex steroids: predictability of in vivo interactions

    Karjalainen, M. J., Neuvonen, P. J. & Backman, J. T., 2008, In : Basic & Clinical Pharmacology & Toxicology. 103, 2, p. 157-165 9 p.

    Research output: Contribution to journalArticleScientificpeer-review

  3. Inhibition of CYP1A2-mediated drug metabolism in vitro and in humans: with special emphasis on rofecoxib and other NSAIDs

    Karjalainen, M. J., 2008, Helsinki: [M. Karjalainen]. 93 p.

    Research output: ThesisDoctoral ThesisCollection of Articles

View all (8) »

ID: 87045